Home
About
Overview
Sharing Data
ORCID
Help
History (44)
A firm foundation.
Specific killing of Rb mutant cancer cells by inactivating TSC2.
NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment.
Merosin-deficient congenital muscular dystrophy with mental retardation and cerebellar cysts unlinked to the LAMA2, FCMD and MEB loci.
Who keeps the gate?
See All 44 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Who keeps the gate?
Who keeps the gate? JAMA. 1993 Nov 03; 270(17):2116-7.
View in:
PubMed
subject areas
Health Care Rationing
Health Care Reform
Referral and Consultation
United States
authors with profiles
Daniel Sulmasy